Mr. Paul Quinn:

I thank the Deputy for the question. A few things have moved on since 2013. Since that period, the expenditure profile has changed somewhat. While I do not have the details of what the Deputy has in front of her, if I recall it correctly, we made a distinction between the overall procurement spend of public bodies and what we call the addressable spend. The difference between the two relates to a number of things we exclude because they would be excluded under public procurement, including, for example, inter-agency expenditure. For example, some bodies would count in their non-pay expenditure moneys they grant or pass on to other public service bodies. The system pushes money out from the centre through a grant system and a lot of that would not be procurable. Other things that would not be procurable would include, in the standard fashion, rent and rates. Again, they are not included. A large sum that we also excluded was money reimbursed for pharmaceuticals through the Primary Care Reimbursement Service, PCRS, which accounts for approximately €1.1 billion or €1.2 billion.